Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-05-24 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
FMR ENG - 170522.pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparency notification' from UCB SA/NV announcing that FMR LLC's shareholding decreased and crossed downwards the 5% threshold, effective May 17, 2022. This notification details the change in voting securities ownership by a major shareholder, which directly corresponds to the definition of a Major Shareholding Notification (MRQ). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it pertains to a specific regulatory disclosure requirement regarding ownership thresholds.
2022-05-24 English
FMR FR - 170522.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Notification de transparence' (Transparency Notification) from FMR LLC to UCB SA, dated May 24, 2022. It explicitly states that FMR LLC's holding of voting shares crossed the 5% threshold downwards ('franchi le seuil de 5% vers le bas') on May 17, 2022. This type of filing, which reports changes in significant share ownership by an entity crossing regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS category.
2022-05-24 French
FMR NL - 170522.pdf
Major Shareholding Notification
2022-05-24 Dutch
220520 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Disposal of own shares' and details a transaction where the company disposed of 400 UCB shares OTC following the exercise of stock options by personnel under a Long-Term Incentive Program. This directly relates to the company buying back or issuing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and contains the transaction details, confirming it is the primary filing, not just an announcement of a filing.
2022-05-20 English
220520 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details a transaction where UCB SA disposed of 400 of its own shares following an option exercise by an employee as part of long-term variable compensation. This directly relates to the company buying back or issuing its own shares, specifically the disposal/alienation of treasury stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and is an official announcement ('Information réglementée').
2022-05-20 French
220520 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details a transaction where UCB shares were transferred to an employee as part of a long-term incentive plan, specifically mentioning the number of shares and the price. This directly relates to the company buying back or issuing its own shares, which corresponds to the definition of 'Transaction in Own Shares'. The filing is dated May 20, 2022, and is marked as 'Gereglementeerde informatie' (Regulated information). This aligns perfectly with the 'Transaction in Own Shares' category (POS). The document length is short (1787 chars), but it contains the substantive details of the transaction, not just an announcement that a report is available, thus it is classified as the transaction report itself.
2022-05-20 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.